LOGO
LOGO

ipo

  • AI Chipmaker Cerebras Launches IPO; Aims For $26.6 Bln Valuation May 04, 2026 13:55 ET

    AI chipmaker Cerebras Systems announced it has launched its initial public offering, aiming to raise up to $3.5 billion. The company plans to offer 28 million shares priced between $115 and $125 each. It also expects to grant underwriters a 30-day option to purchase up to an additional 4.2 million...

  • Hemab Therapeutics Prices IPO At $18 Per Share May 01, 2026 11:04 ET

    Shares of Hemab Therapeutics Holdings Inc., a clinical-stage biotechnology company developing therapies to treat blood coagulation disorders, made their Nasdaq Global Select Market debut under the ticker "COAG" on May 1, 2026.

  • Seaport Therapeutics To List On Nasdaq At $18 Per Share May 01, 2026 03:09 ET

    Shares of Seaport Therapeutics Inc. are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol "SPTX" on May 1, 2026. The company has priced its upsized initial public offering of 14.16 million shares of its common stock at $18.00 per share.

  • Seaport Therapeutics Prices Upsized IPO Of 14.16 Mln Shares At $18 Each May 01, 2026 01:49 ET

    Seaport Therapeutics, Inc. (SPTX) said it has priced its upsized initial public offering of 14.16 million shares at $18 per share, at the top of the target range. The company is expected to raise about $254.9 million in gross proceeds from the offering. It has also granted underwriters a 30-day option...

  • L3Harris Confidentially Submits Draft Filing For Missile Solutions IPO April 30, 2026 04:26 ET

    L3Harris Technologies (LHX), a Disruptor in defense tech, announced Thursday that it has confidentially filed a draft form S-1 with the U.S. Securities and Exchange Commission or SEC related to a proposed initial public offering of common stock in its Missile Solutions business. Terms of the offering,...

  • Avalyn Sets IPO Price At $18 Per Share April 30, 2026 04:03 ET

    Avalyn Pharma Inc., a clinical-stage biopharmaceutical company pioneering inhaled therapies for treating pulmonary fibrosis, is set to begin trading on the Nasdaq Global Select Market under the ticker symbol "AVLN" on April 30, 2026.

  • Avalyn Pharma Prices Upsized $300 Mln IPO At $18 Per Share April 30, 2026 01:25 ET

    Avalyn Pharma Inc. (AVLN), a clinical-stage biopharmaceutical company, announced the pricing of its upsized initial public offering of 16.67 million shares at a price of $18.00 per share. The gross proceeds to Avalyn are expected to be $300 million. The shares are expected to begin trading on the...

  • Hall Chadwick Acquisition Corp II Files For IPO; Plans To Offer 26.5 Mln Units At $10/unit April 30, 2026 01:15 ET

    Hall Chadwick Acquisition Corp II announced Thursday that it had filed with the U.S. SEC on April 21 in connection with its proposed initial public offering on the Nasdaq Global Market under the ticker HCAXU. The Cayman Islands blank check company plans to offer 26.5 million units at $10.00 per unit....

  • Pershing Square Prices $5 Bln Combined IPO April 29, 2026 03:01 ET

    Pershing Square USA, Ltd. (PSUS) and Pershing Square Inc. announced the pricing of their combined initial public offering, with total gross proceeds expected to reach $5 billion. The shares are set to begin trading on the New York Stock Exchange on April 29, 2026, under the symbols "PSUS" for Pershing...

  • Collective Acquisition Prices 22 Mln Units IPO At $10/unit April 29, 2026 01:58 ET

    Collective Acquisition Corp. II, a blank check company, announced that it priced its initial public offering of 22,000,000 units at $10.00 per unit. The units are expected to begin trading on Nasdaq today, under the ticker CAIIU. The company said, each unit made up of one Class A ordinary share...

  • Rare Earths Americas Launches IPO Of 2.8 Mln Shares; Sets Price Range At $17, $19/shr April 28, 2026 08:50 ET

    Rare Earths Americas, Inc. (REA), a critical minerals exploration company, on Tuesday, announced the launch of its initial public offering of approximately 2.8 million shares of stock. The company expects the offering price to be between $17 and $19 per share. The company also granted underwriters...

Global Economics Weekly Update - April 27 – May 01, 2026

May 01, 2026 15:54 ET
Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.

Latest Updates on COVID-19